Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Using Oasis ECM to treat donor site wounds

Official title: Feasibility Study to Compare OASIS Extracellular Matrix to Standard Wound Care for Treatment of Donor Site Wounds

Run by Cook Biotech Incorporated · NCT04079348 · Data updated 2026-11-12

This study is testing if a new treatment called Oasis ECM can help heal donor site wounds better than regular wound care for people over 16 in the UK.

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment40 (estimated)
SponsorCook Biotech Incorporated
Industry-sponsored
Drugs / interventionsradiation
Locations1 site (Manchester, England)
StatusRecruiting
StartedNovember 1, 2020
Main results expectedJune 2025
Study endsDecember 2025
Registry record updatedDecember 17, 2024
Trial IDNCT04079348 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals over 16 years old with a split thickness skin graft donor site wound no larger than 14 x 20 cm.

Probably not a fit

Patients with significant co-morbidities that impair wound healing or those under 16 years old may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of Oasis extracellular matrix (ECM) for treating donor site wounds in patients over 16 years old in the United Kingdom. Approximately 40 participants will be enrolled, with half receiving Oasis ECM and the other half receiving standard wound care. The study aims to assess how well Oasis ECM promotes healing in comparison to conventional methods. Participants must have a specific type of skin graft donor site wound that requires a covering material.

Why it matters

Potential benefit: If successful, this treatment could enhance healing outcomes for patients with donor site wounds.

How similar studies have gone: While Oasis ECM is commercially available, this specific application for donor site wounds is being evaluated for the first time in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Has a split thickness skin graft (STSG) donor site wound no greater than 14 x 20 cm in size requiring placement of a covering material.
2. Has at least 24 hours to consent to study participation.

Exclusion Criteria:

1. Age \< 16 years
2. Patients who, in the opinion of the investigator, have co-morbidities that impair wound healing, such as:

   1. Chronic inflammatory skin condition
   2. Chronic liver failure
   3. Chronic renal failure
   4. Blood-borne viruses (Hep B, Hep C, HIV)
   5. Peripheral vascular disease
   6. Clinically significant anaemia
   7. Uncontrolled diabetes
3. Need for use of the same harvest site (re-cropping)
4. History of radiation therapy to proposed donor site
5. Chronic use of medications known to impair wound healing
6. Chronic use of opioids or neuropathic pain agents
7. Suspected cellulitis, osteomyelitis or septicaemia
8. Patients undergoing haemodialysis
9. Patients requiring spinal/regional block
10. Patients on current anti-coagulant therapy
11. Unable or unwilling to provide informed consent
12. Unable or unwilling to comply with the study follow-up schedule, and procedures
13. Simultaneously participating in another investigational drug or device study (patient must have completed the follow-up phase for the primary endpoint of any previous study at least 30 days prior to enrolment in this study)
14. Allergy or hypersensitivity to materials that are porcine-based
15. Cultural or religious objection to the use of pig or porcine products
16. Known intolerance/allergy to standard wound care products
17. Presence of a local infection at the donor site and/or systemic infection

Where it's running

  • Manchester University NHS Foundation Trust
    Manchester, England, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • New gel treatment for venous leg ulcers

    This study is testing a new gel treatment for people with stubborn venous leg ulcers to see if it helps them heal better than just the usual care.

    Recruiting at 5 sites Phase 3 TR Therapeutics · Jacksonville, Florida and 11 other locations · NCT06707103

  • Comparing palatal wound healing in diabetic and non-diabetic patients

    This study is testing how well wounds in the mouth heal in people with diabetes compared to those without diabetes after surgery to fix gum issues.

    Recruiting at 2 sites Universidade Estadual Paulista Júlio de Mesquita Filho · São José dos Campos, São Paulo and 1 other locations · NCT06540690

  • 4-aminopyridine for faster skin wound healing

    This trial will see if 4-aminopyridine helps small skin wounds heal faster in healthy adults aged 18–70.

    Recruiting Phase 2 University of Arizona · Tucson, Arizona · NCT06333171

  • Robot-assisted reconstruction after surgery for rectal or anal cancer

    This study is testing if using a muscle flap to rebuild the pelvic floor or vagina after robotic surgery for rectal or anal cancer can improve recovery and quality of life for patients.

    Recruiting Oslo University Hospital · Oslo · NCT05689775

  • Predictors of In-Hospital Death in Severe Abdominal Injury

    This study will follow adults with severe abdominal trauma at a large Egyptian hospital to see which factors best predict in-hospital death.

    Recruiting Minia University · Minya, Minya Governorate · NCT07843628

  • Humidification methods in trauma ICU patients on mechanical ventilation

    This study tests whether active heated humidifiers or passive heat-and-moisture exchangers work better in trauma ICU patients who need long-term mechanical ventilation.

    Recruiting Assiut University · Asyut, Asyut Governorate · NCT07713238

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.